Canopy Growth Corp
F:11L
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Canopy Growth Corp
F:11L
|
CA |
|
U
|
US Bancorp
BMV:USB
|
US |
|
Gerdau SA
F:GDUB
|
BR |
|
Ajinomoto Co Inc
F:AJI
|
JP |
|
D
|
Deutsche Telekom AG
XBER:DTE
|
DE |
|
Avi Ltd
F:IZ60
|
ZA |
|
U
|
Unilever PLC
AEX:UNA
|
UK |
|
R
|
RWE AG
F:RWE
|
DE |
|
C
|
CF Industries Holdings Inc
F:C4F
|
US |
|
Geberit AG
OTC:GBERF
|
CH |
|
S
|
Snowflake Inc.
F:5Q5
|
US |
|
S
|
Stellantis NV
DUS:8TI
|
NL |
|
Toyo Tire Corp
OTC:TOTTF
|
JP |
|
N
|
Nippon Yusen KK
XMUN:NYKA
|
JP |
|
PAR Technology Corp
F:35U
|
US |
|
I
|
International Paper Co
BMV:IP
|
US |
|
Jardine Matheson Holdings Ltd
SGX:J36
|
HK |
|
ING Groep NV
NYSE:ING
|
NL |
|
D
|
Dentsu Group Inc
DUS:DEN
|
JP |
|
O
|
Oracle Corp
BMV:ORCL
|
US |
|
Hyundai Motor Co
KRX:005380
|
KR |
|
H
|
Hochtief AG
F:HOT
|
DE |
|
M
|
Mondelez International Inc
XHAM:KTF
|
US |
Bankruptcy Probability
Canopy Growth Corp's probability of bankruptcy is Hidden . The solvency score is Hidden .
We take all the information about a company's solvency, such as how easily it can pay interest on outstanding debt, how much cash it has, the amount of debt, and more, and use it to estimate the probability of bankruptcy.
Solvency Ratios
Solvency Ratios Comparison
Canopy Growth Corp Competitors
| Country | Company | Market Cap | D/E | D/A |
Interest Coverage |
Altman Z-Score |
Quick Ratio |
Current Ratio |
Cash Ratio |
||
|---|---|---|---|---|---|---|---|---|---|---|---|
| CA |
|
Canopy Growth Corp
TSX:WEED
|
706.6m CAD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Eli Lilly and Co
NYSE:LLY
|
919.9B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Johnson & Johnson
NYSE:JNJ
|
535.8B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| CH |
|
Roche Holding AG
SIX:ROG
|
248.4B CHF |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| UK |
|
AstraZeneca PLC
LSE:AZN
|
207B GBP |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Merck & Co Inc
NYSE:MRK
|
277.9B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| CH |
|
Novartis AG
SIX:NOVN
|
216.2B CHF |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| IE |
E
|
Endo International PLC
LSE:0Y5F
|
244.4B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| DK |
|
Novo Nordisk A/S
CSE:NOVO B
|
1.3T DKK |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Pfizer Inc
NYSE:PFE
|
148.5B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Bristol-Myers Squibb Co
NYSE:BMY
|
114.9B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Canopy Growth Corp's probability of bankruptcy is Hidden .
The probability of bankruptcy is estimated using credit risk models that assess financial health, debt levels, interest coverage, and other solvency indicators.
As of the latest report, Canopy Growth Corp has total debt of 242.3m CAD. This includes both short-term (0 CAD) and long-term (242.3m CAD) debt.
You can find a full breakdown on its Balance Sheet.
